Jesse A. Schoonmaker

Bone progenitor dysfunction induces myelodysplasia and secondary leukemia

Charles P. Lin, J. Rommens, B. Ebert, 2010, Nature.

Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease

R. Weissleder, N. Munshi, D. Scadden, 2010, Proceedings of the National Academy of Sciences.

High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical Properties

K. Anderson, M. Bouxsein, N. Munshi, 2009, Clinical Cancer Research.

Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice.

G. Stein, J. Lian, M. Bouxsein, 2008, The Journal of clinical investigation.

The WTX tumor suppressor regulates mesenchymal progenitor cell fate specification.

M. Rivera, R. Baron, D. Haber, 2011, Developmental cell.

A Proteasome Inhibitor, Bortezomib, Inhibits Breast Cancer Growth and Reduces Osteolysis by Downregulating Metastatic Genes

G. Stein, J. Lian, M. Bouxsein, 2010, Clinical Cancer Research.

Bone progenitor dysfunction induces myelodysplasia and secondary leukemia

Charles P. Lin, J. Rommens, B. Ebert, 2010, Nature.